Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Apr 20;9(4):e026174.
doi: 10.1136/bmjopen-2018-026174.

Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents

Karen S W Leong  1   2 , Thilini N Jayasinghe  1 , José G B Derraik  1   2 , Benjamin B Albert  1 , Valentina Chiavaroli  1 , Darren M Svirskis  3 , Kathryn L Beck  4 , Cathryn A Conlon  4 , Yannan Jiang  5 , William Schierding  1 , Tommi Vatanen  1   6 , David J Holland  7 , Justin M O'Sullivan #  1   2 , Wayne S Cutfield #  1   2
Affiliations
Randomized Controlled Trial

Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents

Karen S W Leong et al. BMJ Open. .

Abstract

Introduction: Animal studies showed that germ-free mice inoculated with normal mouse gut bacteria developed obesity, insulin resistance and higher triglyceride levels, despite similar food intake. In humans, an association has been found between obesity and gut microbiome dysbiosis. However, gut microbiome transfer has not been evaluated for the treatment of human obesity. We will examine the effectiveness of gut microbiome transfer using encapsulated material for the treatment of obesity in adolescents.

Methods and analysis: A two-arm, double-blind, placebo-controlled, randomised clinical trial of a single course of gut microbiome transfer will be conducted in 80 obese [body mass index (BMI) ≥30 kg/m2] adolescents (males and females, aged 14-18 years) in Auckland, New Zealand. Healthy lean donors (males and females, aged 18-28 years) will provide fresh stool samples from which bacteria will be isolated and double encapsulated. Participants (recipients) will be randomised at 1:1 to control (placebo) or treatment (gut microbiome transfer), stratified by sex. Recipients will receive 28 capsules over two consecutive mornings (~14 mL of frozen microbial suspension or saline). Clinical assessments will be performed at baseline, 6, 12 and 26 weeks, and will include: anthropometry, blood pressure, fasting metabolic markers, dietary intake, physical activity levels and health-related quality of life. Insulin sensitivity (Matsuda index), gut microbiota population structure characterised by 16S rRNA amplicon sequencing and body composition (using dual-energy X-ray absorptiometry) will be assessed at baseline, 6, 12 and 26 weeks. 24-hour ambulatory blood pressure monitoring will be performed at baseline and at 6 weeks. The primary outcome is BMI SD scores (SDS) at 6 weeks, with BMI SDS at 12 and 26 weeks as secondary outcomes. Other secondary outcomes include insulin sensitivity, adiposity (total body fat percentage) and gut microbial composition at 6, 12 and 26 weeks. Statistical analysis will be performed on the principle of intention to treat.

Ethics and dissemination: Ethics approval was provided by the Northern A Health and Disability Ethics Committee (Ministry of Health, New Zealand; 16/NTA/172). The trial results will be published in peer-reviewed journals and presented at international conferences.

Trial registration number: ACTRN12615001351505; Pre-results.

Keywords: adolescents; clinical trials; microbiology; obesity; paediatric endocrinology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Diagram showing flow of participants (recipients) in the Gut Bugs Trial.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization. Report of the commission on ending childhood obesity. 2016. http://www.who.int/end-childhood-obesity/publications/echo-report/en/ (Accessed 29 Jan 2019).
    1. The NS, Suchindran C, North KE, et al. . Association of adolescent obesity with risk of severe obesity in adulthood. JAMA 2010;304:2042–7. 10.1001/jama.2010.1635 - DOI - PMC - PubMed
    1. Guo SS, Roche AF, Chumlea WC, et al. . The predictive value of childhood body mass index values for overweight at age 35 y. Am J Clin Nutr 1994;59:810–9. 10.1093/ajcn/59.4.810 - DOI - PubMed
    1. Halfon N, Larson K, Slusser W. Associations between obesity and comorbid mental health, developmental, and physical health conditions in a nationally representative sample of US children aged 10 to 17. Acad Pediatr 2013;13:6–13. 10.1016/j.acap.2012.10.007 - DOI - PubMed
    1. Engeland A, Bjørge T, Søgaard AJ, et al. . Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol 2003;157:517–23. 10.1093/aje/kwf219 - DOI - PubMed

Publication types

LinkOut - more resources